Statistical Analysis of Defective Items of Pharmaceutical Wholesale Enterprises

Objective To provide some references and suggestions for promoting the healthy development of pharmaceutical wholesale enterprises,improving the scientific supervision level of the drug regulatory department and ensuring the quality of drugs in the circulation.Methods Retrieving the items on the official websites of the national and provincial drug regulatory departments from 2017 to 2019 that didn’t meet the requirements of the 2016 edition of the Good Supplying Practice in pharmaceutical wholesale enterprises under various inspections,the defective items were summarized and analyzed,and further study of the changes of defective items was conducted.Results and Conclusion 908 pharmaceutical wholesale enterprises had definite defective items,and 218 items violated the Guidelines for On-site Inspection of the Good Supplying Practice,with a cumulative frequency of 3874 defects.Defective items with high-frequency mainly occurred in storage and maintenance,facilities and equipment,personnel and training,general rules and sales.The average defect frequency in each pharmaceutical wholesale enterprises increased year by year,but the proportion of serious defective items decreased significantly.It is recommended that based on improving drug quality,pharmaceutical wholesale enterprises should strengthen personnel training to enhance their awareness of quality responsibility.Besides,the drug regulatory department should increase inspection and crackdown on illegal business operations and the deception of pharmaceutical wholesale enterprises.

Research on Risk Identification of Supply Chain Management in Pharmaceutical Wholesale Enterprises——Taking Enterprise A as an Example

Objective To study the current situation of supply chain management in pharmaceutical wholesale enterprises so that supply chain risks can be identified effectively.Methods Through the analysis of the actual situation of enterprise A,combining with the supply chain problem of the enterprise,the enterprise supply chain risks were found out.Results and Conclusion With the development of pharmaceutical circulation industry,the competition among drug wholesalers has become increasingly fierce.For enterprises,the supply chain risks are increasing,and the traditional upstream and downstream supply risks are transformed into multiple-dimensional risks.The goal of carrying out supply chain risk identification in pharmaceutical wholesale enterprises is to enable key enterprises to discover and understand different types of risks in time so as to improve the management of supply chain.